SummaryGonçalves BM, Teixeira VC, Bittencourt PFS – Anesthesia for Lung Lavage in Pediatric Patients with Pulmonary Alveolar Proteinosis.Background and objectivesPulmonary Alveolar Proteinosis (PAP) is a rare disorder first described in 1958. The Whole-Lung Lavage (WLL) proposed in the 1960s, remains the treatment of choice. Several techniques have been described to perform lung lavage in pediatric patients; however, all have limitation and risks.Case reportFemale patient, aged 6 years and 8 months, 25kg, diagnosed with pulmonary alveolar proteinoisis, who underwent whole-lung lavage by sequential lobar fiberoptic bronchoscopy under general anesthesia and spontaneous ventilation
Background: Pulmonary alveolar proteinosis ( PAP) is a rare disease, characterized by excessive intr...
Pulmonary alveolar proteinosis (PAP) – an unusual diffuse lung disease characterized by alveolar acc...
Background: Whole lung lavage (WLL) is the current standard of care treatment for patients affected ...
SummaryGonçalves BM, Teixeira VC, Bittencourt PFS – Anesthesia for Lung Lavage in Pediatric Patients...
Background: Pulmonary alveolar proteinosis (PAP) is a rare disease in children, characterized by int...
Described in 1958 by Rosen, Pulmonary Alveolar Proteinosis (PAP) represents a rare disease involving...
SummaryPulmonary alveolar proteinosis (PAP) is a rare, heterogeneous diffuse lung disease in childho...
This report demonstrates the results following massive simultaneous lavage of both lungs in two brot...
Pulmonary alveolar proteinosis (PAP) is a rare disease in children characterized by intra-alveolar a...
BACKGROUND: Pulmonary alveolar proteinosis (PAP) is a rare disease characterised by accumulation of ...
New therapies have emerged in the treatment of pulmonary alveolar proteinosis (PAP) and, therefore, ...
Objective: The aim of this study was to present the evolution of four patients presenting pulmonary ...
BACKGROUND: Whole lung lavage (WLL) is the current standard of care treatment for patients affected...
Background. Pulmonary alveolar proteinosis is a rare disorder characterized by a large accumulation ...
BACKGROUND: New therapies have emerged in the treatment of pulmonary alveolar proteinosis (PAP) and,...
Background: Pulmonary alveolar proteinosis ( PAP) is a rare disease, characterized by excessive intr...
Pulmonary alveolar proteinosis (PAP) – an unusual diffuse lung disease characterized by alveolar acc...
Background: Whole lung lavage (WLL) is the current standard of care treatment for patients affected ...
SummaryGonçalves BM, Teixeira VC, Bittencourt PFS – Anesthesia for Lung Lavage in Pediatric Patients...
Background: Pulmonary alveolar proteinosis (PAP) is a rare disease in children, characterized by int...
Described in 1958 by Rosen, Pulmonary Alveolar Proteinosis (PAP) represents a rare disease involving...
SummaryPulmonary alveolar proteinosis (PAP) is a rare, heterogeneous diffuse lung disease in childho...
This report demonstrates the results following massive simultaneous lavage of both lungs in two brot...
Pulmonary alveolar proteinosis (PAP) is a rare disease in children characterized by intra-alveolar a...
BACKGROUND: Pulmonary alveolar proteinosis (PAP) is a rare disease characterised by accumulation of ...
New therapies have emerged in the treatment of pulmonary alveolar proteinosis (PAP) and, therefore, ...
Objective: The aim of this study was to present the evolution of four patients presenting pulmonary ...
BACKGROUND: Whole lung lavage (WLL) is the current standard of care treatment for patients affected...
Background. Pulmonary alveolar proteinosis is a rare disorder characterized by a large accumulation ...
BACKGROUND: New therapies have emerged in the treatment of pulmonary alveolar proteinosis (PAP) and,...
Background: Pulmonary alveolar proteinosis ( PAP) is a rare disease, characterized by excessive intr...
Pulmonary alveolar proteinosis (PAP) – an unusual diffuse lung disease characterized by alveolar acc...
Background: Whole lung lavage (WLL) is the current standard of care treatment for patients affected ...